Published in Cell Microbiol on May 01, 2006
Modeling systems-level regulation of host immune responses. PLoS Comput Biol (2007) 1.56
O antigen protects Bordetella parapertussis from complement. Infect Immun (2008) 1.04
Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J Bacteriol (2008) 1.03
Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect Immun (2009) 0.97
Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine. Infect Immun (2007) 0.89
Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infect Immun (2010) 0.89
A novel sensor kinase is required for Bordetella bronchiseptica to colonize the lower respiratory tract. Infect Immun (2011) 0.76
Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy. Medicine (Baltimore) (2016) 0.75
PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med (2010) 4.74
Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice. Blood (2011) 2.22
Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol (2009) 1.76
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76
Role of antibodies in immunity to Bordetella infections. Infect Immun (2003) 1.71
Molecular signature of hypersaline adaptation: insights from genome and proteome composition of halophilic prokaryotes. Genome Biol (2008) 1.64
Modeling systems-level regulation of host immune responses. PLoS Comput Biol (2007) 1.56
HIV integration site distributions in resting and activated CD4+ T cells infected in culture. AIDS (2009) 1.46
Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells. J Virol (2009) 1.45
HIV latency and integration site placement in five cell-based models. Retrovirology (2013) 1.42
Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. Cancer Res (2006) 1.40
Genomic and genetic analysis of Bordetella bacteriophages encoding reverse transcriptase-mediated tropism-switching cassettes. J Bacteriol (2004) 1.36
Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol (2003) 1.35
Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency. PLoS Pathog (2012) 1.34
Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest (2005) 1.32
Role of Bordetella O antigen in respiratory tract infection. Infect Immun (2003) 1.32
The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect Immun (2006) 1.31
Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis (2004) 1.31
Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens. BMC Genomics (2012) 1.30
Evolution and emergence of Bordetella in humans. Trends Microbiol (2005) 1.25
Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun (2005) 1.23
Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis. J Biol Chem (2004) 1.23
MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: implications for Toll-like receptor signaling. Infect Immun (2005) 1.22
Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine (2010) 1.18
Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge. Virology (2007) 1.16
Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV. PLoS One (2013) 1.15
Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice. Hepatology (2008) 1.15
Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis (2004) 1.14
Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infect Immun (2004) 1.13
Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun (2002) 1.13
Cell-to-cell transmission of viruses. Curr Opin Virol (2012) 1.13
Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence. J Immunol (2005) 1.13
Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. Eur J Immunol (2004) 1.10
The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity. Infect Immun (2007) 1.09
The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. J Immunol (2005) 1.08
Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression. Toxicol Sci (2008) 1.07
pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect Immun (2004) 1.06
O antigen protects Bordetella parapertussis from complement. Infect Immun (2008) 1.04
Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J Bacteriol (2008) 1.03
Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS One (2009) 1.01
(-)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice. Obesity (Silver Spring) (2011) 1.01
Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infect Immun (2005) 1.00
Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis. Carcinogenesis (2008) 0.99
(-)-Epigallocatechin-3-gallate increases the expression of genes related to fat oxidation in the skeletal muscle of high fat-fed mice. Food Funct (2011) 0.98
Evolution of acute infections and the invasion-persistence trade-off. Am Nat (2009) 0.98
Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect Immun (2009) 0.97
PPARbeta/delta protects against experimental colitis through a ligand-independent mechanism. Dig Dis Sci (2007) 0.96
Inhibition of Interleukin-10 Signaling Induces Microbiota-dependent Chronic Colitis in Apolipoprotein E Deficient Mice. Inflamm Bowel Dis (2016) 0.94
Pertussis pathogenesis--what we know and what we don't know. J Infect Dis (2014) 0.92
Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxin. J Infect Dis (2007) 0.91
Intracellular trafficking of Bordetella pertussis in human macrophages. Infect Immun (2010) 0.91
Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. Microbes Infect (2007) 0.91
O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PLoS One (2009) 0.90
Comparative role of immunoglobulin A in protective immunity against the Bordetellae. Infect Immun (2007) 0.90
Constraint-based network model of pathogen-immune system interactions. J R Soc Interface (2008) 0.89
IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response. J Immunol (2009) 0.89
Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proc Biol Sci (2010) 0.89
Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission. Infect Immun (2013) 0.89
Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infect Immun (2010) 0.89
Lack of cross-protection against Bordetella holmesii after pertussis vaccination. Emerg Infect Dis (2012) 0.88
Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infect Immun (2004) 0.87
The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis. Infect Immun (2009) 0.87
Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. PLoS One (2009) 0.87
Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2. Mol Cancer Ther (2010) 0.86
A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo. PLoS One (2012) 0.85
Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infect Immun (2009) 0.84
Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression. Carcinogenesis (2010) 0.83
Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica. Infect Immun (2009) 0.83
Evaluation of the stability, bioavailability, and hypersensitivity of the omega-3 derived anti-leukemic prostaglandin: Δ(12)-prostaglandin J3. PLoS One (2013) 0.82
Bordetella pertussis acquires resistance to complement-mediated killing in vivo. Infect Immun (2003) 0.82
IEIIS Meeting minireview: Bordetella evolution: lipid A and Toll-like receptor 4. J Endotoxin Res (2007) 0.81
Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. J Immunol (2011) 0.81
Phenotypic and genomic analysis of hypervirulent human-associated Bordetella bronchiseptica. BMC Microbiol (2012) 0.80
Comparison of the agar block and Lieber-DeCarli diets to study chronic alcohol consumption in an aging model of Fischer 344 female rats. J Pharmacol Toxicol Methods (2012) 0.79
Immunoreactive and bioactive growth hormone responses to resistance exercise in men who are lean or obese. J Appl Physiol (1985) (2011) 0.79
Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen. Infect Immun (2012) 0.79
sigE facilitates the adaptation of Bordetella bronchiseptica to stress conditions and lethal infection in immunocompromised mice. BMC Microbiol (2012) 0.79
Identifying the age cohort responsible for transmission in a natural outbreak of Bordetella bronchiseptica. PLoS Pathog (2010) 0.79
IACUC issues related to animal models of aging. ILAR J (2011) 0.78
Resident microbiota affect Bordetella pertussis infectious dose and host specificity. J Infect Dis (2013) 0.78
Horizontally acquired divergent O-antigen contributes to escape from cross-immunity in the classical bordetellae. BMC Evol Biol (2013) 0.77
Identification of a CO2 responsive regulon in Bordetella. PLoS One (2012) 0.77
Immunization with pneumococcal polysaccharide serotype 3 and lipopolysaccharide modulates lung and liver inflammation during a virulent Streptococcus pneumoniae infection in mice. Clin Vaccine Immunol (2013) 0.77
Use of perphenazine to control cannibalism in DBA/1 mice. Comp Med (2002) 0.76
Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic. J Biol Chem (2010) 0.76
Ectopic Expression of Innate Immune Protein, Lipocalin-2, in Lactococcus lactis Protects Against Gut and Environmental Stressors. Inflamm Bowel Dis (2017) 0.75
The husbandry and care of dendrobatid frogs. Contemp Top Lab Anim Sci (2005) 0.75
Human electromuscular incapacitation devices characterization: a comparative study on stress and the physiological effects on swine. J Strength Cond Res (2012) 0.75
The effects of continuous application of the TASER X26 waveform on Sus scrofa. J Forensic Sci (2013) 0.75
Teaching ethical aptitude to graduate student researchers. Account Res (2013) 0.75
Vitamin A toxicity and vitamin E deficiency in a rabbit colony. Contemp Top Lab Anim Sci (2004) 0.75